Search research articles
Contact Us
Filters
Showing results (1-10 of 66) with videos related to
Page
of 7
Sort By:
Trends in Molecular Medicine
|
February 8, 2005
A heretical view on the role of NO and cGMP in vascular proliferative diseases
Robert Feil, Susanne Feil, Franz Hofmann
Circulation Research
|
March 27, 2004
SM22alpha modulates vascular smooth muscle cell phenotype during atherogenesis
Susanne Feil, Franz Hofmann, Robert Feil
Methods in Molecular Biology (Clifton, N.J.)
|
March 7, 2009
Inducible Cre mice
Susanne Feil, Nadejda Valtcheva, Robert Feil
Methods in Molecular Biology (Clifton, N.J.)
|
July 28, 2014
Genetic inducible fate mapping in adult mice using tamoxifen-dependent Cre recombinases
Susanne Feil, Jana Krauss, Martin Thunemann, et al.
British Journal of Pharmacology
|
April 21, 2021
Visualising and understanding cGMP signals in the cardiovascular system
Robert Feil, Moritz Lehners, Daniel Stehle, et al.
Journal of Cardiovascular Development and Disease
|
April 20, 2018
cGMP Signaling and Vascular Smooth Muscle Cell Plasticity
Moritz Lehners, Hyazinth Dobrowinski, Susanne Feil, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 5, 2003
A proatherogenic role for cGMP-dependent protein kinase in vascular smooth muscle cells
Wiebke Wolfsgruber, Susanne Feil, Sabine Brummer, et al.
Plos One
|
January 22, 2009
cGMP-dependent protein kinase type I is implicated in the regulation of the timing and quality of sleep and wakefulness
Sonja Langmesser, Paul Franken, Susanne Feil, et al.
Plos One
|
March 17, 2009
cGMP-dependent protein kinase I is crucial for angiogenesis and postnatal vasculogenesis
Alexandra Aicher, Christopher Heeschen, Susanne Feil, et al.
The FEBS Journal
|
January 22, 2009
cGMP-dependent protein kinase II and aldosterone secretion
Beate Spiessberger, Dominik Bernhard, Stefan Herrmann, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 66) with videos related to
Sort By:
Page
of 7
Trends in Molecular Medicine
|
February 8, 2005
A heretical view on the role of NO and cGMP in vascular proliferative diseases
Robert Feil, Susanne Feil, Franz Hofmann
Circulation Research
|
March 27, 2004
SM22alpha modulates vascular smooth muscle cell phenotype during atherogenesis
Susanne Feil, Franz Hofmann, Robert Feil
Methods in Molecular Biology (Clifton, N.J.)
|
March 7, 2009
Inducible Cre mice
Susanne Feil, Nadejda Valtcheva, Robert Feil
Methods in Molecular Biology (Clifton, N.J.)
|
July 28, 2014
Genetic inducible fate mapping in adult mice using tamoxifen-dependent Cre recombinases
Susanne Feil, Jana Krauss, Martin Thunemann, et al.
British Journal of Pharmacology
|
April 21, 2021
Visualising and understanding cGMP signals in the cardiovascular system
Robert Feil, Moritz Lehners, Daniel Stehle, et al.
Journal of Cardiovascular Development and Disease
|
April 20, 2018
cGMP Signaling and Vascular Smooth Muscle Cell Plasticity
Moritz Lehners, Hyazinth Dobrowinski, Susanne Feil, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 5, 2003
A proatherogenic role for cGMP-dependent protein kinase in vascular smooth muscle cells
Wiebke Wolfsgruber, Susanne Feil, Sabine Brummer, et al.
Plos One
|
January 22, 2009
cGMP-dependent protein kinase type I is implicated in the regulation of the timing and quality of sleep and wakefulness
Sonja Langmesser, Paul Franken, Susanne Feil, et al.
Plos One
|
March 17, 2009
cGMP-dependent protein kinase I is crucial for angiogenesis and postnatal vasculogenesis
Alexandra Aicher, Christopher Heeschen, Susanne Feil, et al.
The FEBS Journal
|
January 22, 2009
cGMP-dependent protein kinase II and aldosterone secretion
Beate Spiessberger, Dominik Bernhard, Stefan Herrmann, et al.
Page
of 7